Radiopharmaceutical Market

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

Radiopharmaceutical Market contains market size and forecasts of Radiopharmaceutical in global, including the following market information:

Global Radiopharmaceutical Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Radiopharmaceutical Market Sales, 2017-2022, 2023-2028, (M Doses)

Global top five Radiopharmaceutical companies in 2021 (%)

The global Radiopharmaceutical market was valued at 6956.7 million in 2021 and is projected to reach US$ 11660 million by 2028, at a CAGR of 7.7% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Actinium-225 Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Radiopharmaceutical include Bracco Imaging, Bayer, Mallinckrodt, Nordion, Triad Isotopes, Lantheus, IBA Group, GE Healthcare and China Isotope & Radiation, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Radiopharmaceutical manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Radiopharmaceutical Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Doses)

Global Radiopharmaceutical Market Segment Percentages, by Type, 2021 (%)

Actinium-225

Lutetium-177

Radium-223

Holmium-166

Other

Global Radiopharmaceutical Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (M Doses)

Global Radiopharmaceutical Market Segment Percentages, by Application, 2021 (%)

Oncology

Cardiology

Other

Global Radiopharmaceutical Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M Doses)

Global Radiopharmaceutical Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Radiopharmaceutical revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Radiopharmaceutical revenues share in global market, 2021 (%)

Key companies Radiopharmaceutical sales in global market, 2017-2022 (Estimated), (M Doses)

Key companies Radiopharmaceutical sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Bracco Imaging

Bayer

Mallinckrodt

Nordion

Triad Isotopes

Lantheus

IBA Group

GE Healthcare

China Isotope & Radiation

Jubilant Pharma

Eli Lilly

Advanced Accelerator Applications

SIEMENS

Dongcheng

Navidea